Gravitate Health FHIR Implementation Guide (FHIR R4), published by . This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/hl7-eu/gravitate-health-ips/ and changes regularly. See the Directory of published versions
Example Bundle: Alex Gravitate's IPS
id:
gravitate-alex-himss
Composition status:
final
Composition Type:
Patient summary Document
Subject:
identifier:
Alex-1
Name:
Alex Gravitate
active:
true
gender:
male
Birth Date:
1975-10-05
Sections
Problem List
Condition:
Metabolic syndrome X (237602007)
clinicalStatus:
active
Condition:
Primary carcinoma of prostate (1259388006)
clinicalStatus:
active
asserter:
Dr. Walter Waltz
onsetDateTime:
2018
Condition:
Diabetes mellitus type 2 (disorder) (44054006)
clinicalStatus:
active
asserter:
Dr. Walter Waltz
onsetDateTime:
2018
Condition:
Overweight (238131007)
clinicalStatus:
active
asserter:
Dr. Walter Waltz
onsetDateTime:
2018
Medication Summary
Medication:
Metformin 500 mg PO with the two largest meals → slowly titrate to 1 g BID
status:
active
Medication Detail:
-
System
https://www.gravitatehealth.eu/sid/doc
Code:
himss-metformin [Metformin 500 mg tablets]
-
System
https://spor.ema.europa.eu/pmswi
Code:
himss-6 [Metformin 500 mg]
Dose Form:
Tablet
Ingredient:
metformin (http://fdasis.nlm.nih.gov#9100L32L2N)
strength:
500 mg/1 Tablet
Route:
Oral use
Medication:
Atorvastatin 40 mg PO nightly
status:
active
Medication Detail:
-
System
https://www.gravitatehealth.eu/sid/doc
Code:
himss-Atorvastatin [Atorvastatin 40 mg]
-
System
https://spor.ema.europa.eu/pmswi
Code:
himss-7 [Atorvastatin 40 mg]
Dose Form:
Coated tablet
Ingredient:
FOLIC ACID (http://fdasis.nlm.nih.gov#935E97BOY8)
strength:
40 mg/1 Tablet
Route:
Oral use
Medication:
Semaglutide 2.4 mg SC once weekly
status:
active
Medication Detail:
-
System
https://www.gravitatehealth.eu/sid/doc
Code:
himss-semaglutide [Semaglutide 2.4 mg]
-
System
https://spor.ema.europa.eu/pmswi
Code:
himss-9 [Semaglutide 2.4 mg ]
Dose Form:
Effervescent tablet
Ingredient:
Calcium carbonate (http://fdasis.nlm.nih.gov#H0G9379FGK)
strength:
2.4 mg/1 Dose
Route:
Oral use
Medication:
Finasteride 5 mg PO daily
status:
active
Medication Detail:
-
System
https://www.gravitatehealth.eu/sid/doc
Code:
himss-finasteride [Finasteride 5 mg]
-
System
https://spor.ema.europa.eu/pmswi
Code:
himss-10 [Finasteride 5 mg]
Dose Form:
Effervescent tablet
Ingredient:
Calcium carbonate (http://fdasis.nlm.nih.gov#H0G9379FGK)
strength:
5 mg/1 Tablet
Route:
Oral use